SGEN News and Press, Seagen Inc. From 12/29/23

2023-12-29 10:48:17 ET More on Pfizer The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Pfizer: Buy The Panic Pharma and biotech deal values spike 35% ...

2023-12-28 01:30:44 ET Summary Pfizer is one of the largest American pharmaceutical companies, developing medicines and vaccines using cutting-edge technologies to save and improve the lives of millions worldwide. Pfizer's revenue for the three months that ended in 2023 was about ...

2023-12-21 13:05:16 ET Summary Valuations in the biotech market have fallen, making it a good time for acquisitions in the industry. Investors should focus on commercial-stage biotech companies that generate revenue, as they provide a safety net in uncertain economic conditions. ...

PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer PR Newswire – PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – &...

2023-12-14 08:40:14 ET More on Pfizer Pfizer 2024 Guidance - Relentless COVID Pain Isn't Over Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024 Pfizer hits 52-week low, drags COVID vacci...

2023-12-13 13:06:50 ET Summary Pfizer cuts financial guidance for 2024 due to slumping Covid drug demand and inability of the Seagen contribution to offset losses. The biopharma forecasts an EPS jump back to ~$2.15 in 2024, but the Covid business continues to impact financials. ...

2023-12-13 11:18:26 ET More on Pfizer Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024 Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks Biggest stock movers tod...

2023-12-13 07:13:01 ET More on Pfizer Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024 Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks Pfizer to close Seagen b...

2023-12-12 11:07:43 ET Summary Investors should consider tax-loss selling before December ends to offset capital gains. Two characteristics to consider for selling stocks are stocks bought at a higher price and broken companies with weak long-term prospects. Stock grades, sent...

Seagen Inc. (NASDAQ: SGEN) is one of today's top gainers. The company's shares have moved -0.24% on the day to $214.09. Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS,...